TrialJournal of gynecologic oncology2020

The post-progression survival of patients with recurrent or persistent ovarian clear cell carcinoma: results from a randomized phase III study in JGOG3017/GCIG.

Eiji Kondo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.